Keyword: Sangamo Therapeutics

News

Sangamo Reviews Options as Drugmakers Terminate Deals

22.03.2023 -

US biotech Sangamo Therapeutics is studying alternative options to advance its neurological disease programs after both Novartis and Biogen ended their respective...

News

Kite and Sangamo Therapeutics in Oncology Pact

15.03.2018 - US-based Kite Pharma, part of Gilead Sciences since October 2017, is collaborating with Sangamo Therapeutics to develop next-generation engineered cell therapies to treat cancer...